Skip to main content
Premium Trial:

Request an Annual Quote

Johnson & Johnson Is First Customer for New 96-Well Affy Chip

NEW YORK, Sept. 24 (GenomeWeb News) - Affymetrix said today that Johnson & Johnson Pharmaceutical Research & Development is the first early access customer for its new GeneChip HighThroughputArray, a 96-well plate with one of Affy's Human Genome U133 arrays in each well.


The HTA system also includes an automated assay that is similar to Affymetrix's standard gene expression assay, and a software system that allows users to track samples and data.

Affymetrix did not indicate the price of the new GeneChip HTA system, which it is launching today.